Adrenaline inhibits the immunological activation of human basophils at pharmacological and ultra-low doses

Medical Science Monitor

Volumn 16, Issue 7, 2010, Pages 227-232

  Mannaioni, Pier Francesco ^a   Mastroianni, Rosanna ^a   Mastrangelo, Domenico ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Adrenaline; Basophil activation; Ultra low doses

Indexed keywords

ADRENALIN; ANTIGEN; CD203 ANTIGEN; CD63 ANTIGEN; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; PROPRANOLOL; UNCLASSIFIED DRUG; ANTI-IGE; ANTIIDIOTYPIC ANTIBODY; ENPP3 PROTEIN, HUMAN; FIBRINOGEN RECEPTOR; INORGANIC PYROPHOSPHATASE; LEUKOCYTE ANTIGEN; LYSOSOMAL PROTEIN GP53; PHOSPHODIESTERASE;

ANTIBODY BLOOD LEVEL; ARTICLE; BASOPHIL; BLOOD SAMPLING; CELL ACTIVATION; HISTAMINE RELEASE; HUMAN; IMMUNOREACTIVITY; IN VITRO STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS; ANTIGENS, CD; BASOPHILS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; FLOW CYTOMETRY; HISTAMINE RELEASE; HUMANS; PHOSPHORIC DIESTER HYDROLASES; PLATELET MEMBRANE GLYCOPROTEINS; PROPRANOLOL; PYROPHOSPHATASES;

EID: 77954797585     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Shild H: Histamine release and anaphylactic shock in isolated lungs of guinea-pig. Q Jl Exp Physiol, 1936; 26: 165-78.
2. Assem ESK, Schild H: Inhibition by sympathomimetic amines of histamine release induced by antigen in passively sensitized human lung. Nature, 1969; 224: 1028-29.
3. Johnson AR, Moran NC: Inhibition of the release of histamine from rat mast cells The effect of cold and adrenergic drugs on release of histamine by compound 48/80 and by Antigen. J Pharmacol, 1970; 175: 632-40.
4. Elenkov IJ, Chrousos GP: Stress system organization, physiology and immunomodulation. Neuroimmunomodulatio, 2006; 13: 257-67.
5. Lichtenstein LM, Margolis S: Histamine release in vitro: inhibition by catechol-amines and methylxanthines. Science, 1968; 161: 902-3.
6. Lichtenstein LM, Gillespie E: Inhibition of histamine release by histamine controlled by H2 receptor. Nature, 1973; 244: 287-88.
7. Lichtenstein LM, Gillespie E: The effect of the H1and H2 antihistamines on "allergic" histamine release and its inhibition by histamine. J Pharmacol, 1975; 192: 441-50.
8. Belon P et al: Inhibition of human basophil degranulation by successive histamine dilutions: Results of a European multi-centre trial. Inflamm Res, 1999; 48(Suppl.1): S17-18.
9. Boumiza R et al: The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy, 2005; 3: 1-8.
10. Belon P et al: Histamine dilutions modulate basophil activation. Inflamm Res, 2004; 53: 181-88.
11. Eberlein-Konig B et al: In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy. J Invest. Allergol Clin Immunol, 2006; 16: 5-10.
12. Shore PA, Burkhalter A, Cohn VH: A method for the fluorimetric assay of histamine in tissues. J Pharmacol, 1959; 127: 182-86.
13. Kremzer LT, Wilson IB: A procedure for the determination of histamine. Biochem Biophys Acta, 1961; 50: 364-67.
14. Bergendorff A, Uvnas B: Storage of 5-hydroxytryptamine in rat mast cells. Evidence for an ionic binding to carboxyl group in granule heparinprotein complex. Acta Physiol Scand, 1972; 84: 320-21.
15. Erdmann SM, Sachs B, Kwiecien R et al: The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy. Allergy, 2004; 59: 1102-9.
16. Buring HJ, Streble A, Valent P: The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis. Intern Arch Allergy and Immunology, 2004; 133: 317-29.
17. Abuaf N, Rostane H, Rajoely B et al: Comparison of two basophil activation markers CD 63 and CD 203c in the diagnosis of amoxicillin allergy. Clin Exp Allergy, 2008; 38: 921-28.
18. Yasnowsky KM, Dreskin SC, Efaw B et al: Chronic urticaria sera increase basophil CD203c expression. J All Clin Immunol, 2006; 117(6): 1430-34.
19. Sterba PM, Alexander V, Eckman JA et al: Relationship Between AllergenInduced Basophil Histamine Release and CD203c Stimulation During Omalizumab Treatment. J All Clin Immunol, 2009; 123(2 Suppl.): S198
20. Calabresi EG: Hormesis: changing views on the dose-response. Mutation Res 2002; 511: 181-89.
21. Eizayaga FX, Aguejouf O, Belon P, Doutremepuich C: Platelet aggregation in portal hypertension and its modification by low doses of aspirin. Pathophysiol Haemost Thromb, 2005; 34: 29-34.
22. Fereidoni M, Javan M, Semnanian S, Ahmadiani A: Chronic forced swim stress inhibits ultra-low doses induced hyperalgesia in rats. Behav Pharmacol, 2007; 18: 667-72.
23. Hamann S, Sloan PA, Witt W: Low-dose intrathecal naloxone to enhance intrathecal morphine analgesia: a case report. J Opioid Manag, 2008; 4: 251-54.
24. Leri F: Co-administration of opioid agonists and antagonists in addiction and pain medicine. Expert Opin Pharmacother, 2008; 9: 1387-96.
25. Bahremand A, Shafaroodi H, Ghasemi M et al: The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose of naltrexone in mice. Epilepsy Res, 2008; 81: 44-51.